Bank of New York Mellon’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.2M Buy
666,260
+67,006
+11% +$5.68M 0.01% 952
2026
Q1
$50.1M Sell
599,254
-22,625
-4% -$1.86M 0.01% 998
2025
Q4
$57M Sell
621,879
-23,964
-4% -$2.29M 0.01% 919
2025
Q3
$61.2M Sell
645,843
-13,716
-2% -$1.29M 0.01% 890
2025
Q2
$69.1M Sell
659,559
-4,303
-0.6% -$408K 0.01% 794
2025
Q1
$58.7M Sell
663,862
-82,020
-11% -$8.41M 0.01% 867
2024
Q4
$71.6M Buy
745,882
+996
+0.1% +$92.8K 0.01% 803
2024
Q3
$61M Sell
744,886
-156,288
-17% -$12.1M 0.01% 903
2024
Q2
$77.7M Buy
901,174
+98,994
+12% +$8M 0.01% 774
2024
Q1
$65.5M Sell
802,180
-28,324
-3% -$2.21M 0.01% 885
2023
Q4
$55.1M Sell
830,504
-22,303
-3% -$1.55M 0.01% 982
2023
Q3
$62.3M Buy
852,807
+2,077
+0.2% +$140K 0.01% 860
2023
Q2
$53.7M Sell
850,730
-2,953
-0.3% -$171K 0.01% 971
2023
Q1
$50.1M Sell
853,683
-39,016
-4% -$2.37M 0.01% 1010
2022
Q4
$55M Sell
892,699
-40,651
-4% -$2.73M 0.01% 925
2022
Q3
$62.7M Buy
933,350
+13,268
+1% +$840K 0.02% 813
2022
Q2
$56.5M Sell
920,082
-4,412
-0.5% -$283K 0.01% 907
2022
Q1
$62.3M Buy
924,494
+32,662
+4% +$1.76M 0.01% 954
2021
Q4
$39.5M Buy
891,832
+6,373
+0.7% +$371K 0.01% 1314
2021
Q3
$57.3M Sell
885,459
-46,552
-5% -$3.23M 0.01% 1041
2021
Q2
$75M Buy
932,011
+3,226
+0.3% +$246K 0.01% 874
2021
Q1
$63.2M Buy
928,785
+27,823
+3% +$2.19M 0.01% 954
2020
Q4
$62.8M Sell
900,962
-15,290
-2% -$951K 0.01% 917
2020
Q3
$47.1M Buy
916,252
+8,487
+0.9% +$466K 0.01% 951
2020
Q2
$53.3M Buy
907,765
+35,184
+4% +$1.95M 0.01% 848
2020
Q1
$44.1M Buy
872,581
+3,704
+0.4% +$246K 0.01% 825
2019
Q4
$64.4M Buy
868,877
+1,558
+0.2% +$97.2K 0.02% 835
2019
Q3
$49.6M Buy
867,319
+149,012
+21% +$9.89M 0.01% 952
2019
Q2
$47M Sell
718,307
-446,602
-38% -$31.1M 0.01% 1013
2019
Q1
$86.2M Buy
1,164,909
+174,507
+18% +$12.3M 0.02% 658
2018
Q4
$59.1M Buy
990,402
+118,080
+14% +$9.52M 0.02% 787
2018
Q3
$82.4M Buy
872,322
+169,985
+24% +$14.6M 0.02% 709
2018
Q2
$52.7M Sell
702,337
-959
-0.1% -$68.9K 0.01% 967
2018
Q1
$42.6M Sell
703,296
-200,810
-22% -$10.9M 0.01% 1100
2017
Q4
$42.2M Sell
904,106
-23,150
-2% -$1.15M 0.01% 1112
2017
Q3
$46.9M Buy
927,256
+37,737
+4% +$1.76M 0.01% 1037
2017
Q2
$44.3M Buy
889,519
+73,015
+9% +$3.41M 0.01% 1045
2017
Q1
$34.7M Buy
816,504
+264,604
+48% +$11.7M 0.01% 1211
2016
Q4
$22.4M Buy
551,900
+21,740
+4% +$840K 0.01% 1466
2016
Q3
$20.1M Buy
530,160
+54,327
+11% +$1.72M 0.01% 1466
2016
Q2
$14.5M Buy
475,833
+50,828
+12% +$1.33M ﹤0.01% 1627
2016
Q1
$10.5M Buy
425,005
+13,018
+3% +$279K ﹤0.01% 1814
2015
Q4
$10.3M Buy
411,987
+10,890
+3% +$335K ﹤0.01% 1826
2015
Q3
$11.9M Buy
401,097
+79,021
+25% +$2.48M ﹤0.01% 1761
2015
Q2
$10.3M Buy
322,076
+265,980
+474% +$7.14M ﹤0.01% 1950
2015
Q1
$1.4M Buy
56,096
+4,353
+8% +$94.4K ﹤0.01% 3096
2014
Q4
$1.32M Buy
51,743
+17,754
+52% +$385K ﹤0.01% 3133
2014
Q3
$622K Buy
+33,989
New +$652K ﹤0.01% 3545

Other funds holding HQY

Bank of New York Mellon's HQY Position: Q2 2026 in Review

Bank of New York Mellon increased its HealthEquity (HQY) stake by 11% in Q2 2026, buying an estimated $5.68M and bringing the position to 666,260 shares worth $60.2M. The position accounts for 0.01% of the portfolio, ranked #952.

Bank of New York Mellon first reported a position in HQY in Q3 2014 and has held it in 48 quarters since. The position peaked at $86.2M in Q1 2019. 321 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Bank of New York Mellon held 666,260 shares of HealthEquity worth $60.2M as of Q2 2026.
  • Bank of New York Mellon bought 67,006 HealthEquity shares in Q2 2026, an estimated $5.68M.
  • HealthEquity made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #952 holding.
  • Bank of New York Mellon first reported a position in HealthEquity in Q3 2014 and has held it in 48 quarters since.
  • Bank of New York Mellon's HealthEquity position peaked at $86.2M in Q1 2019.
  • 321 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.